Caplight Directory>Investors>Ming Bioventures>Mingbioventures


Ming Bioventures

Ming Bioventures

Jiangsumingbioventures.com

Overview

Ming Bioventures is a venture capital firm founded in 2018. Based in Suzhou, China, the firm focuses on early-stage investments in the life science sectors, including innovative drugs, medical devices, emerging biotechnology, and medical diagnostics.

Portfolio Companies

4

Investments

CompanyDateStageLead
Innovo TherapeuticsDec 2023Early FundingCo-investor
Innovo TherapeuticsMay 2022AngelLead
Help TherapeuticsNov 2021Series CLead
Abogen BiosciencesApr 2021Series BCo-investor
Elpiscience BiopharmaceuticalsDec 2019Series BCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersJiangsu
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.